Tag Archives: developing countries
Will WHO Member States Pony Up for Neglected Diseases?
Recognizing that traditional market forces – namely incentives related to intellectual property and a steady demand for products – have failed in developing countries, the World Health Organization (WHO) asked a member state-nominated group to come up with ways to fund R&D and pay for the treatment of neglected diseases in the world’s poorest nations. [...]
Posted in Emerging Markets, Global, IP, Legal, Manufacturing, Market Access, R&D, leadership, pricing Also tagged developing nations, funding, neglected diseases, Neglected Tropical Diseases, Novartis, Paul Herrling, R&D, tropical diseases, WHO, World Health Assembly Leave a comment
Big Pharmas Mystery Market Segment
Just who are those “bottom billion” potential consumers in developing countries? A new report sheds some light.
Big Pharma’s future depends on tapping new sources of business opportunity. One segment on virtually everyone’s must do list is the “bottom billion”—poor consumers in the world’s poorer countries. Market analysis suggests that when the bottom billion’s potential purchasing [...]
Posted in Corporate Responsibility, Global, Strategy Also tagged access to medicines Leave a comment

UN Pact Scuttles Anti-Vaccine Provision